Print
Email
Print Edition Stories
Cambridge medical device company OmniGuide Inc., which develops optical scalpels for various types of surgical procedures, has named former Covidien (NYSE: COV) executive Scott Flora as president, CEO and board member.
Flora will take on his new role on Nov. 1, replacing OmniGuide founder Yoel Fink, who will remain as chairman while taking on the role of director of the Research Laboratory of Electronics at MIT. Flora has more than 20 years of experience in the medical device sector, most recently serving as global business unit president of surgical devices at Covidien.
Prior to working at Covidien, Flora spent 15 years at medical device maker Smith & Nephew, including work as president and general manager of the orthopedics reconstruction business. He received a bachelor’s degree in marketing from Millikin University, and has completed executive programs at INSEAD, Wharton and Yale.
OmniGuide’s products are sold under the BeamPath brand. The core technology, based on an omnidirectional reflector was developed by MIT researchers, including Fink in 1998, and was licensed to OmniGuide in 2003. OmniGuide said its CO2 laser scalpels have been used in more than 25,000 surgical procedures in fields including neurosurgery, otolaryngology, gynecology, pulmonology and gastroenterology.
In 2009, OmniGuide was one of 28 companies awarded $25 million in tax incentives by the Massachusetts Life Sciences Center, with OmniGuide receiving $540,000 in incentives. Earlier that year OmniGuide reported that it had pulled in $1.8 million in an equity round, which followed a $25 million investment round in 2010.
Comments
If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.
RSS Feeds
